D-Leucylglycylglycine combines a D-configured hydrophobic residue with two flexible glycines, enabling stereochemical and conformational analysis. The sequence helps dissect how D-residues alter backbone geometry and recognition by proteases. Researchers evaluate its folding behavior and stability in solution. Applications include chirality studies, peptidomimetic design, and enzyme-specificity profiling.
CAT No: R2369
CAS No:18625-22-4
Synonyms/Alias:18625-22-4;D-Leucylglycylglycine;(R)-2-(2-(2-Amino-4-methylpentanamido)acetamido)acetic acid;2-[[2-[[(2R)-2-amino-4-methylpentanoyl]amino]acetyl]amino]acetic acid;CHEMBL1222388;H-D-Leu-Gly-Gly-OH;2-[[2-[[(2R)-2-azaniumyl-4-methylpentanoyl]amino]acetyl]amino]acetate;D-Leucyl-glycyl-glycine;Glycine,D-leucylglycyl-;Glycine, N-(N-D-leucylglycyl)-;N-(N-D-Leucylglycyl)glycine;2-{2-[(2R)-2-Amino-4-methylpentanamido]acetamido}acetic acid;EINECS 242-457-0;D-LEU-GLY-GLY;(([(2-Amino-4-methylpentanoyl)amino]acetyl)amino)acetic acid #;{2-[(2R)-2-amino-4-methylpentanamido]acetamido}acetic acid;DTXSID601314917;(R)-2-(2-(2-Amino-4-methylpentanamido)-acetamido)acetic acid;TAA62522;BDBM50410267;AKOS015854090;NSC 523307;AS-70790;CS-0320767;L0031;NS00085542;A12180;(R)-2-(2-(2-Amino-4-methylpentanamido)acetamido)aceticacid;
1. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis
3. Peptides as Active Ingredients: A Challenge for Cosmeceutical Industry
4. Cationic cell-penetrating peptides are potent furin inhibitors
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.